Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Erlib 150mg Tablet

Prescription Icon
Prescription Required

Marketer

Neon Laboratories Ltd

Salt Composition

Erlotinib (150mg)

Overview Erlib 150mg Tablet

Erlib 150mg tablets treat non-small cell lung and pancreatic cancers. Administer on an empty stomach, or one hour before or two hours after eating. Continue treatment as directed by your physician; duration depends on individual response. Follow your doctor's instructions precisely; improper use or overdose can lead to severe adverse effects. Benefits may take weeks or months to appear; do not discontinue without consulting your doctor. Common side effects include nausea, vomiting, tiredness, skin rash, and weight loss. Severe diarrhea requires increased fluid intake or medical attention. Photosensitivity may occur; use sunscreen and protective clothing outdoors. Report mouth sores, vision changes, or breathing problems immediately. Liver function monitoring may be recommended. Inform your healthcare provider of all other medications you're taking, as interactions are possible. This medication is contraindicated during pregnancy and breastfeeding; effective contraception is crucial for both partners. Smoking cessation is advised as it can interfere with treatment efficacy. Maintain a two-hour interval between Erlib and antacids or other medications.

Uses of Erlib 150mg Tablet

Cancers of the pancreas and non-small-cell lungs

Major Benefits of Erlib 150mg Tablet:

Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment period. Ingest the entire tablet; avoid chewing, crushing, or fracturing it. Erlib 150mg Tablets should be taken on an empty stomach.

Common Side effects of Erlib 150mg Tablet:

  • Abdominal pain
  • Bone pain
  • Breathlessness
  • Constipation
  • Cough
  • Diarrhea
  • Fatigue
  • Fever
  • Infection
  • Muscle pain
  • Nausea
  • Rash
  • Stomatitis (Inflammation of the mouth)
  • Vomiting
  • Weight loss

How to use Erlib 150mg Tablet:

Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and duration. Ingest the entire tablet without chewing, crushing, or fracturing it. Erlib 150mg tablets should be taken on an empty stomach.

How Erlib 150mg Tablet works:

Erlib 150mg tablets are used in cancer treatment. Lung cancer cells possess epidermal growth factor receptors (EGFRs) which regulate their proliferation. The drug functions by attaching to these EGFRs, thereby blocking the EGFR-driven cancer cell growth signals and halting tumor expansion.

SAFETY ADVICE

AlcoholAlcoholCONSULT YOUR DOCTOR

Alcohol consumption alongside Erlib 150mg Tablet lacks established safety data. Seek medical advice before combining them.

PregnancyPregnancyCONSULT YOUR DOCTOR

Using Erlib 150mg tablets during pregnancy poses a confirmed risk to the unborn child. Therefore, it's contraindicated. In exceptional, life-threatening circumstances, a physician might prescribe it if the potential advantages outweigh the known hazards. Always seek medical advice.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

Lactation and Erlib 150mg tablets are likely incompatible. Available human data indicates potential transfer to breast milk, posing a possible risk to the infant.

DrivingDrivingCONSULT YOUR DOCTOR

Driving ability may be unaffected by Erlib 150mg Tablet; however, refrain from driving if experiencing symptoms impairing concentration or reaction time.

KidneyKidneySAFE IF PRESCRIBED

For patients with kidney disease, Erlib 150mg Tablet is considered safe and requires no dosage alteration. However, its use is contraindicated in individuals with severely impaired kidney function.

LiverLiverCAUTION

Patients with hepatic impairment should use Erlib 150mg tablets cautiously; dosage modification may be necessary. Physician consultation is advised.

What if you forget to take Erlib 150mg Tablet :

Omit any missed Erlib 150mg Tablet dose and resume your usual medication regimen. Avoid taking a double dose.

Facts to Know About Erlib 150mg Tablet

LabelValue
Chemical Category Quinazoline-based compound
Developing Habits No.
Treatment Category Cancer Medications

FAQs on Erlib 150mg Tablet

Take one Erlib 150mg tablet orally once daily, on an empty stomach, at least one hour before or two hours after a meal, as directed by your doctor. For consistent dosing, take it at the same time each day.
Erlib 150mg Tablet isn't a standard chemotherapy drug; it's a kinase inhibitor. By blocking a protein that triggers cancer cell growth, it helps slow or halt cancer's spread.
Continue taking your Erlib 150mg tablet daily as directed by your doctor. Treatment length varies individually.
Smoking significantly reduces the effectiveness of Erlib 150mg Tablet. Therefore, it's recommended to quit smoking before starting this medication. Continued or altered smoking habits may require your doctor to adjust your Erlib 150mg Tablet dosage.
Skin rashes are a possible side effect of Erlib 150mg Tablets, but don't discontinue use without consulting your doctor. They can advise on managing the rash. Meanwhile, minimize sun exposure by using sunscreen and protective clothing.
Do not become pregnant while taking Erlib 150mg Tablets. Women of childbearing age must use reliable contraception during and for one month after treatment.
Erlib 150mg tablets may cause conjunctivitis and dry eyes. Seek immediate medical attention if you experience sudden or worsening eye redness, pain, excessive tearing, blurred vision, or light sensitivity, as this may require urgent treatment.
Contact your doctor immediately if you experience sudden shortness of breath with cough or fever, severe or persistent diarrhea, appetite loss, nausea, or vomiting. Also, seek medical attention if you develop or experience worsening eye redness and pain, excessive tearing, blurred vision, and/or light sensitivity. Finally, inform your doctor if you're taking a statin and develop unexplained muscle pain, tenderness, weakness, or cramps.
Erlib 150mg Tablet
1,728
MRP 2,000
13% off